Chembio Diagn (CEMI) Misses Q4 EPS by 2c

Chembio Diagn (NASDAQ: CEMI) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $7.1 million.

For earnings history and earnings-related data on Chembio Diagn (CEMI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Diana Shipping withdraws bid to acquire Genco Shipping
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c